The bar chart provides a breakdown of a drug company’s total sales between 2002 and 2006, with a further classification by region.
In general, while great variations are witnessed in the percentage of this company’s sales in America and Europe, only the figure for Asia experienced an upward trend during the examined period.
From 2002 to 2004, it is noticeable that whereas a gradual increase was seen in the proportion of Asia and Europe, that of America dropped. In 2002, America led the chart, contributing 41% of the total sales. This was followed by the figures for Europe and Asia, registering 34% and 25%, respectively. Subsequently, while these two regions both saw a growth in their data, the proportion of this company’s sales in America significantly dropped to 27% in 2004, which was the lowest information.
Between 2004 and 2006, Asia’s percentage of total sales continued to rise, overtaking the top position. Specifically, Asia increasingly accounts for more proportion of total sales, ending the period with 40%. Similarly, an upward trend is observed in the data for America, increasing by 3% to 30% in 2006. 30% was also the final figure for Europe after experiencing an 8-percent decrease from 2004.